A Novel Gene Signature Based on CDC20 and FCN3 for Prediction of Prognosis and Immune Features in Patients with Hepatocellular Carcinoma

<div>Identification of disease-free genes having a correlation with survival in HCC using the top 10 reduced genes. (a) Low expression of FCN3 had a correlation with poor prognosis of HCC patients. (b) Univariate Cox regression analyses.</div>

Journal of Immunology Research

fig6

Figure 6

Figure 6: A Novel Gene Signature Based on CDC20 and FCN3 for Prediction of Prognosis and Immune Features in Patients with Hepatocellular Carcinoma 